Clinical Trials Logo

Transgenderism clinical trials

View clinical trials related to Transgenderism.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06149065 Completed - Acne Clinical Trials

Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study

Start date: June 5, 2021
Phase:
Study type: Observational [Patient Registry]

The goal of this observational cross-sectional study is to identify factors associated with severity of acne in Thai transmen receiving masculinizing hormone therapy. The main questions it aims to answer are: - What are the factors associated with severity of acne in transmen? - Does masculinizing hormone therapy associate with the severity of acne in transmen? Participants will be asked to complete an online questionnaire and allow to take pictures of their face for acne assessment purpose.

NCT ID: NCT05728853 Completed - Transgenderism Clinical Trials

Is Bioimpedance Analysis Accurate in Transgender Males?

Start date: April 20, 2023
Phase:
Study type: Observational

Accurate fat mass and muscle mass assessment is an informative marker of an individual's health. However, the optimal method for assessing body composition in transgender males remains to be determined. Here, the investigators aim to compare body composition estimates in transgender males by bioimpedance analysis using the reference settings for males and females and by

NCT ID: NCT05666102 Completed - HIV Infections Clinical Trials

Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The goal of this pilot study is to gather and analyze qualitative data from focus groups with Transgender men who have sex with men (TMSM) to learn more about the life experiences unique to TMSM that influence their attitudes and beliefs about HIV risk, as well as to better understand the intersections of these specific sexual and gender identities.

NCT ID: NCT05163860 Completed - Health Behavior Clinical Trials

Family Relationships and Nutrition in TGGD Youth and Young Adults

Start date: December 27, 2021
Phase:
Study type: Observational

The purpose of this study is to assess how family relationships are related to health and nutrition behaviors among transgender and gender diverse youth and young adults.

NCT ID: NCT04969003 Completed - Depression Clinical Trials

Reducing Transphobia Among Adolescents Through a Brief Video Intervention

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The purposes of this new study are to test among adolescent viewers the utility of brief video-based interventions to: 1. reduce transphobia; 2. reduce depression-related stigma and increase likelihood of treatment-seeking; and 3. examine the role of viewer's sex (male / female / non-binary), race (Black vs non-Black), and sexual orientation (straight vs LGBQ) as independent factors on the outcomes of interest.

NCT ID: NCT04708600 Completed - Gender Dysphoria Clinical Trials

Effectiveness of Speech Therapy in Trans Women.

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

One of the greatest hurdles in the transition of transgender persons is that voice, speech and communication are not congruent with the desired gender. Since hormone treatment does not affect the voice in male-to-female transgender persons (trans women), speech therapy is the treatment of choice to develop a more feminine communication. Speech therapy must focus on aspects of communication that play an important role in listener perceptions of the speakers gender. Results of a systematic review and meta-analysis showed that those aspects are primarily fundamental frequency of the voice and resonance. However, effectiveness studies of speech interventions in transwomen are extremely limited and show methodological limitations. The purpose of this project is to investigate the short-term and longterm impact of speech exercises for pitch and resonance on (a) acoustic voice characteristics, (b) listener perceptions of femininity using a visual analogue scale and binary gender identification (male versus female voice), and (c) self-perception and psychosocial functioning in trans women using a randomized sham-controlled trial and cross-over design.

NCT ID: NCT04545450 Completed - Hypogonadism Clinical Trials

Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen

DUTMUSCLE-20
Start date: November 4, 2008
Phase: Phase 3
Study type: Interventional

To compare the effects on body composition and muscle strengthof 54-weeks treatment with of testosterone undecanoate combined with placebo or with the 5a-reductase inhibitor dutasteride

NCT ID: NCT04515654 Completed - Stigma, Social Clinical Trials

Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre: Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre

Start date: January 15, 2019
Phase: N/A
Study type: Interventional

Importance: Societal stigma gravely impedes occupational justice for trans individuals, producing vast health disparities for this population. Objective: Test feasibility and impact of an intervention to reduce stigma and improve trans wellbeing Design: Convergent parallel mixed methods Setting: Community/Webinar Participants: 42 audience members and 6 trans interviewees Intervention: Virtual, narrative-informed play reading and moderated discussion about gender diversity and affirmative care Outcomes and Measures: The valid and reliable Acceptance and Action Questionnaire - Stigma (AAQ-S) assesses stigma beliefs; An open-ended qualitative question assesses trans interviewees' experiences

NCT ID: NCT04482920 Completed - Kidney Diseases Clinical Trials

Effect of Hormone Therapy on Renal Function

Start date: April 15, 2021
Phase:
Study type: Observational

The purpose of this study is to understand the effects of testosterone or estradiol on kidney function in transgender adolescents and young adults.

NCT ID: NCT04454970 Completed - Transgenderism Clinical Trials

Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction

SAFE
Start date: September 16, 2022
Phase: N/A
Study type: Interventional

Inserting a urinary catheter in transgender men following penile reconstruction is difficult and usually requires specialist input. Specialist input may not always be readily available and clinicians may resort to suprapubic catheterisation with the associated risk of injury to the bowel or blood vessels. There is a need for an evidence-based protocol to guide clinicians faced with having to catheterise one of these patients. The investigators will evaluate how successful a specialised catheter (Urethrotech UCD®) is compared with a standard Foley catheter for catheterisation of these patients. The Urethrotech UCD® is already used for difficult catheterisation in cisgender men. Transgender men undergoing insertion of an inflatable penile prosthesis under general anaesthesia will be recruited and randomly assigned to have either the Urethrotech UCD® or Foley catheter for the first attempt at urethral catheterisation (required for standard care). If unsuccessful, flexible cystoscopy will be performed and a Foley catheter will be inserted over a guidewire. The catheter is generally removed the next day prior to discharge from hospital. Patients will be followed-up in 30 days by phone.